Presentations
“Pharmacoeconomical cost and benefit analysis of radiopharmaceuticals for therapy of metastatic bone cancer”
Lev Voloznev, Karlova M., Chistyakov D.
New opportunities of a radionuclide therapy in treating metastatic bone cancer
Krilov V.V., Kochetova T.U.
Optimal visualization of Neuroendocrine tumors G3
Prof. Dr. Shiraev S.V.
Dose Escalation Study with 188Re-Zoledronic Acid in Patients with Painful Bone Metastases
Tatiana Kochetova, Valeriy Krylov, Lev Volosnev.
The effectivity of radiopharmaceuticals in treating breast cancer with bone metastasis
Dr. Krilov V.V.
Using111In-Octreotide in a Single-photon emission computed tomography research to diagnose neuroendocrine tumors
Prof. Dr. Shiraev S.V.
Re-188: New Era in radionuclide therapy
Dr. Krilov V.V.
Radionuclide therapy for metastatic bone cancer patients. New opportunities
Kochetova T.U.
Diagnostic and Treatment of Pancreatic Neuroendocrine tumors
Prof. Dr. Shiraev S.V.
Radionuclide theranostics in treating Neuroendocrine tumors
Prof. Dr. Shiraev S.V.
188Re-based radiopharmaceuticals for treatment bone metastasis. Comparative data.
Tatiana Kochetova.
Radionuclide diagnostic and therapy for Neuroendocrine tumors
Prof. Dr. Shiraev S.V.
Radionuclide therapy for bone metastasis
Dr. Krilov V.V.
Theranostic approach for Neuroendocrine tumors: 111In, 68Ga, 177Lu
PhD Voloznev L.V.
Modern approach to manage Neuroendocrine tumors
PhD Rasylova N.V.
Radionuclide diagnostic and therapy for Neuroendocrine tumors in Russia and abroad. Complex cases discussion
Prof. Shiraev S.V.
Radionuclide therapy for bone metastasis. First International scientific conference
Dr. Krivol V.V.
Re-188 Zoledronic acid: from the first trial to latest clinical data
Kochetova T. U.
Radionuclide therapy for bone metastasis: latest opportunities and perspectives
Dr. Krilov V.V.